FTLF vs. MDWD, BGXX, CDXC, ACB, BTMD, AGEN, ZURA, PRPH, OMGA, and SGMT
Should you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include MediWound (MDWD), Bright Green (BGXX), ChromaDex (CDXC), Aurora Cannabis (ACB), biote (BTMD), Agenus (AGEN), Zura Bio (ZURA), ProPhase Labs (PRPH), Omega Therapeutics (OMGA), and Sagimet Biosciences (SGMT). These companies are all part of the "medical" sector.
FitLife Brands (NASDAQ:FTLF) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations, community ranking and risk.
MediWound received 388 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 62.38% of users gave MediWound an outperform vote while only 0.00% of users gave FitLife Brands an outperform vote.
2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 46.8% of MediWound shares are held by institutional investors. 61.2% of FitLife Brands shares are held by company insiders. Comparatively, 9.2% of MediWound shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
FitLife Brands has a net margin of 10.05% compared to MediWound's net margin of -35.94%. FitLife Brands' return on equity of 27.17% beat MediWound's return on equity.
FitLife Brands has higher revenue and earnings than MediWound. MediWound is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
In the previous week, FitLife Brands and FitLife Brands both had 1 articles in the media. FitLife Brands' average media sentiment score of 0.00 equaled MediWound'saverage media sentiment score.
FitLife Brands has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500.
MediWound has a consensus price target of $32.00, suggesting a potential upside of 75.44%. Given MediWound's higher possible upside, analysts plainly believe MediWound is more favorable than FitLife Brands.
Summary
FitLife Brands beats MediWound on 8 of the 15 factors compared between the two stocks.
Get FitLife Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
FitLife Brands Competitors List
Related Companies and Tools
